Guy Goodwin
FMedSci
Emeritus Professor of Psychiatry
The development of better ways to treat mood disorders
My research interests are in the treatment of bipolar disorder and the application of neuroscience and technology in understanding the neurobiology of mood disorders, with a focus on developing new treatments.
I was formerly W.A.Handley Chair of Psychiatry and head of the University department of Psychiatry (1996-2011).
I am a Fellow of the American College of Neuropsychopharmacology, and have previously held the positions of President of the British Association for Psychopharmacology (2004–2005) and of the European College of Neuropsychopharmacology (ECNP, 2013-2016).
I am an Emeritus Senior Investigator on the faculty of UK National Institute for Health Research (NIHR).
I am a Thomson Reuters highly cited researcher (top 1% in field).
Recent publications
-
Efficacy of digital cognitive behavioural therapy for symptoms of generalised anxiety disorder: a study protocol for a randomised controlled trial
Journal article
Gu J. et al, (2020), Trials, 21
-
Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial
Journal article
Carl JR. et al, (2020), Depression and Anxiety
-
Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands.
Journal article
Taquet M. et al, (2020), JAMA Psychiatry
-
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action.
Journal article
Manchia M. et al, (2020), Eur Neuropsychopharmacol, 36, 121 - 136
-
Why sleep matters for young people who may get depressed.
Journal article
Goodwin GM., (2020), Interface Focus, 10